| Name |
Number of Shares held before new shares allotted under DRP |
Number of New Shares Allotted under DRP |
Consideration for the New Shares |
Total Number of Shares held Post-DRP (Total to date) |
Nature of Interest |
| |
| Unit |
Percentage |
|
Unit |
Percentage |
| Urudra a/l N. Sarvanantham |
76,800 |
6,200 |
0.001% |
RM1.41 per share |
83,000 |
0.012% |
Direct |
| Ng Su Yee |
63,255 |
4,016 |
0.001%
|
RM1.41 per share |
67,271 |
0.010% |
Direct |
| Krisnakumara-Reddi a/l Kesava-Reddi |
0* |
2,102 |
0.0003% |
RM1.41 per share |
2,102 |
0.0003% |
Direct |
Note:
* As announced on 22 July 2020, Mr. Krisnakumara-Reddi a/l Kesava-Reddi had on 22 July 2020 disposed his entire shareholding in Duopharma Biotech. However, the disposal was after the book closure date for the single-tier final dividend and DRP on 14 July 2020 and as such, Mr. Krisnakumara was entitled to exercise the DRP accordingly.
This announcement dated 13 August 2020.